We have the capability for the design and execution of the project with quick access to inventory for generating target molecules in a remarkably shorter time frame enabling quick biological screenings for affinities. With the target properties in mind, we deliver molecules, by applying our extensive knowledge in drug discovery and in optimizing various NCEs, improved physicochemical properties, Pharmacokinetic (PK) properties, and/or often circumventing toxicology-related concerns at different stages of discovery. This approach has always been pivotal in the design of 25-100 compound-focused libraries – customized to avoid the common pitfalls in drug discovery processes and to enhance the chance of hit identification or optimization with improved properties. Our large and selective in-house collection of acids, aldehydes, amines, phenols, boronic acids, and heterocyclic halides are carefully selected to be compatible with most of the drug discovery concepts, where we focus on a high-performance library design that can exponentially accelerate the success rate of a discovery program.

Two decades of experience
300 compounds in 2 months (across 5 different scaffolds)
Quick access to inventory
Fast turnaround time
Quick initiation of small libraries and scaffold synthesis
Mass directed purification systems for faster TAT
Parallel synthesis
Design and synthesis of partial PROTAC libraries
We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
JANUARY 04, 2021
Physicochemical properties of drug forecast its ADME chance, however, the formulation development strategy or dosage form is decided based on the bioavailability, commencement and duration of therapeutic response. An ideal strategy for formulation development should consider the dose of the drug, intended route of administration, anatomical and phys...
Read More
Peptide Development and Manufacturing Peptides are short chains of amino acids that are linked by peptide bonds. Several peptides linked together are called polypeptides. A protein contains one or more polypeptides. Therefore, proteins are long chains of amino acids held together by peptide bonds. ...
Read More2005
A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...
Read More2005
An improved and rapid synthesis of mefenamic acid based indole derivatives has been achieved via the ligand free Cu-catalyzed coupling-cyclization method under ultrasound irradiation. This simple, straightforward and inexpensive one-pot method involved the reaction of a terminal alkyne derived from mefenamic acid with 2- iodosulfanilides in the presence of CuI ...
Read More2005
The formal synthesis of Cladospolide-C and its analog is achieved by using enantiopure (R)-g evalerolactone 10. The significant points of this synthesis are the stereoselective dihydroxylation of a, bunsaturated ester 16 using Sharpless protocol, Wittig olefination of g evalerolactol 6 with triphenylphosphonium iodide salt 7, one pot selective oxidation ...
Read MoreYou are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market